Literature DB >> 19377982

Isolating aptamers using capillary electrophoresis-SELEX (CE-SELEX).

Renee K Mosing1, Michael T Bowser.   

Abstract

SELEX (systematic evolution of ligands by exponential enrichment) is a process for isolating DNA or RNA sequences with high affinity and selectivity for molecular targets from random sequence libraries. These sequences are commonly referred to as aptamers. The process typically requires 10-15 cycles of enrichment, PCR amplification and nucleic acid purification to obtain high-affinity aptamers. We have demonstrated that using capillary electrophoresis (CE) as an enrichment step greatly improves the efficiency of the process. CE-SELEX is capable of isolating high-affinity aptamers in as little as 2-4 rounds of selection, shortening the process time from several weeks to as little as a few days.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19377982     DOI: 10.1007/978-1-59745-557-2_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  Molecular Elucidation of Disease Biomarkers at the Interface of Chemistry and Biology.

Authors:  Liqin Zhang; Shuo Wan; Ying Jiang; Yanyue Wang; Ting Fu; Qiaoling Liu; Zhijuan Cao; Liping Qiu; Weihong Tan
Journal:  J Am Chem Soc       Date:  2017-02-07       Impact factor: 15.419

Review 2.  Advances in the development of aptamer drug conjugates for targeted drug delivery.

Authors:  Ke Chen; Bo Liu; Bo Yu; Wen Zhong; Yi Lu; Jiani Zhang; Jie Liao; Jun Liu; Ying Pu; Liping Qiu; Liqin Zhang; Huixia Liu; Weihong Tan
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-10-31

Review 3.  Emerging applications of riboswitches in chemical biology.

Authors:  Shana Topp; Justin P Gallivan
Journal:  ACS Chem Biol       Date:  2010-01-15       Impact factor: 5.100

4.  Enhanced functional potential of nucleic acid aptamer libraries patterned to increase secondary structure.

Authors:  Karen M Ruff; Thomas M Snyder; David R Liu
Journal:  J Am Chem Soc       Date:  2010-07-14       Impact factor: 15.419

5.  Cell-specific aptamers as emerging therapeutics.

Authors:  Cindy Meyer; Ulrich Hahn; Andrea Rentmeister
Journal:  J Nucleic Acids       Date:  2011-08-28

Review 6.  Aptamers: A Feasible Technology in Cancer Immunotherapy.

Authors:  M M Soldevilla; H Villanueva; F Pastor
Journal:  J Immunol Res       Date:  2016-06-20       Impact factor: 4.818

Review 7.  Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems.

Authors:  Feng Jiang; Biao Liu; Jun Lu; Fangfei Li; Defang Li; Chao Liang; Lei Dang; Jin Liu; Bing He; Shaikh Atik Badshah; Cheng Lu; Xiaojuan He; Baosheng Guo; Xiao-Bing Zhang; Weihong Tan; Aiping Lu; Ge Zhang
Journal:  Int J Mol Sci       Date:  2015-10-09       Impact factor: 5.923

Review 8.  Aptamer Technology: Adjunct Therapy for Malaria.

Authors:  Nik Abdul Aziz Nik Kamarudin; Nurul Adila Mohammed; Khairul Mohd Fadzli Mustaffa
Journal:  Biomedicines       Date:  2017-01-04

Review 9.  Bioapplications of Cell-SELEX-Generated Aptamers in Cancer Diagnostics, Therapeutics, Theranostics and Biomarker Discovery: A Comprehensive Review.

Authors:  Xuehui Pang; Cheng Cui; Shuo Wan; Ying Jiang; Liangliang Zhang; Lian Xia; Long Li; Xiaowei Li; Weihong Tan
Journal:  Cancers (Basel)       Date:  2018-02-09       Impact factor: 6.639

Review 10.  Aptamers and Aptasensors for Highly Specific Recognition and Sensitive Detection of Marine Biotoxins: Recent Advances and Perspectives.

Authors:  Lianhui Zhao; Yunfei Huang; Yiyang Dong; Xutiange Han; Sai Wang; Xingguo Liang
Journal:  Toxins (Basel)       Date:  2018-10-25       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.